Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Triple Negative Breast Neoplasms × seribantumab × 1 year × Clear all

Sponsor

Conditions

Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1 Gallbladder Neoplasms 1 Fibromatosis, Gingival, 2 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Breast Neoplasms 1 Bile Duct Neoplasms 1

Interventions

pembrolizumab 83 Carboplatin 57 Paclitaxel 48 Cyclophosphamide 32 Specimen Handling 25 sacituzumab govitecan 24 Capecitabine 24 130-nm albumin-bound paclitaxel 22 Magnetic Resonance Spectroscopy 21 Doxorubicin 18 Biopsy 18 Albumin-Bound Paclitaxel 17 olaparib 15 Gemcitabine 15 Nivolumab 14 Taxes 13 toripalimab 12 atezolizumab 12 Drug Therapy 12 Docetaxel 12 eribulin 10 Epirubicin 10 Bevacizumab 10 durvalumab 9 Radiotherapy 9 Cisplatin 8 veliparib 6 fludarabine 6 Radiation 6 Mastectomy, Segmental 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡